SUBSCRIBE

Parkinson’s Research Update: Multifaceted Approach for a Multifaceted Disease
Science
Parkinson’s Research Update: Multifaceted Approach for a Multifaceted Disease
How insights into Parkinson’s neuropathology are shaping potential transformational approaches.

ABOUT THE NEWSROOM

Here you will find media contacts, plus the latest news, stories and insights from Lundbeck US. Lundbeck is a global pharmaceutical company solely focused on the brain, and our 900+ U.S. employees are committed to improving the lives of people affected by psychiatric and neurological disorders.

Science
Science
Perspective
PERSPECTIVES
our-impact
Our Impact
press-release
News Releases
New for 2020: Sidekicks® Program Expands Opportunities for Parkinson’s Disease Community to Build Positive Connections Through Intergenerational Storysharing
News Releases
New for 2020: Sidekicks® Program Expands Opportunities for Parkinson’s Disease Community to Build Positive Connections Through Intergenerational Storysharing
Lundbeck Ranked Among World’s Climate Elite
News Releases
Lundbeck Ranked Among World’s Climate Elite
Celebrating Parkinson’s Care Partners
Our Impact
Celebrating Parkinson’s Care Partners
Lundbeck Named a 2019 Chicago Tribune Top Workplace
News Releases
Lundbeck Named a 2019 Chicago Tribune Top Workplace
Lundbeck completes the acquisition of Alder BioPharmaceuticals - a company committed to transforming migraine treatment and prevention
News Releases
Lundbeck completes the acquisition of Alder BioPharmaceuticals - a company committed to transforming migraine treatment and prevention

This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site are subject to the terms and conditions as set out in our Privacy Policy and Terms of Use. 

© Copyright 2018 Lundbeck. All rights reserved.